ArticlePloS one2025
Exploring support for medicalized female genital mutilation/cutting: A study on migrant women living in Italy.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The medicalization of female genital mutilation/cutting (FGM/C) as a harm reduction strategy is a highly debated issue, although largely unexplored among migrants living outside practising countries. This study investigates the extent of the support for FGM/C conditioned on its medicalization among migrant women from FGM/C-practising countries residing in Italy, and the characteristics of women supporting the practice. Data are from a national survey on FGM/C conducted in Italy in 2016, covering a representative sample of 1,378 women aged 18 + who were born in Nigeria, Egypt, Eritrea, Senegal, Burkina Faso, Somalia, and Ivory Coast. A discrete choice framework and a multinomial probit choice model are adopted to analyze women's preferences about FGM/C continuation and medicalization. Findings indicate that, compared with women who support the practice unconditionally, the requirement of medicalization correlates with higher educational level, age, being in a couple, and being from a country where FGM/C is more commonly medicalized. Perceived benefits linked to increased support for FGM/C medicalization include religious approval, better marriage prospects, cleanliness, and conformity to traditional cultural values. Our data show that higher education is a critical, but not unique, factor in understanding the support for FGM/C in its medicalized form.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.